The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriers.
Elizabeth K BancroftElizabeth C PageMark N BrookJennifer PopeSarah ThomasKathryn MyhillBrian T HelfandPooja TalatyKai-Ren OngEmma DouglasJackie CookDerek J RosarioMonica SalinasSaundra S BuysJo AnsonRosemarie DavidsonMark LongmuirLucy SideDiana M EcclesMarc TischkowitzAmy TaylorMara CruellasEduard Perez BallesteroRuth CleaverMohini VarugheseJulian BarwellMandy LeButtLynn GreenhalghRachel HartAshraf AzzabiIrene JobsonLynn CogleyD Gareth EvansJeanette RothwellNatalie TaylorMatthew HogbenSibel Sayanull nullRosalind A EelesNeil K AaronsonPublished in: BJU international (2024)
This is the first study to report the longitudinal psychosocial impact of a targeted PrCa screening programme for BRCA1 and BRCA2 carriers. The results reassure that an annual PSA-based screening programme does not have an adverse impact on psychosocial health or health-related quality of life in these higher-risk individuals. These results are important as more PrCa screening is targeted to higher-risk groups.